Watchlist Price Alert

REGENXBIO Inc. (RGNX)

NASDAQ: RGNX · Real-Time Price · USD

9.80

-0.60 (-5.77%)

At close: May 05, 2025, 3:59 PM

9.70

-1.02%

After-hours: May 05, 2025, 04:33 PM EDT

REGENXBIO Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	83.33M	90.24M	112.72M	470.35M	154.57M	35.23M	218.5M	10.39M	4.59M
Cost of Revenue	33.57M	37.21M	54.55M	51.83M	35.71M	8.24M	9.64M	1.71M	959K
Gross Profit	49.76M	53.03M	58.18M	418.51M	118.85M	26.99M	208.87M	8.68M	3.63M
Operating Income	-233.35M	-268.13M	-262.88M	159.98M	-119.23M	-149M	88.1M	-75.89M	-65.34M
Interest Income	174K	25K	342K	719K	4.27M	2.95M	8.95M	n/a	n/a
Pretax Income	-227.1M	-263.65M	-280.4M	141.25M	-106.01M	-97.49M	104.12M	-73.17M	-63.4M
Net Income	-227.1M	-263.49M	-280.32M	127.84M	-111.25M	-94.73M	99.94M	-73.17M	-62.97M
Selling & General & Admin	76.62M	88.49M	85.28M	79.33M	63.82M	51.81M	36.85M	27.23M	23.59M
Research & Development	208.52M	232.27M	242.45M	181.44M	166.29M	124.19M	83.87M	57.22M	45.48M
Other Expenses	-2.03M	397K	-6.68M	-2.24M	7.97M	-10K	42K	116K	-102K
Operating Expenses	285.14M	321.16M	321.06M	258.53M	238.09M	175.99M	120.77M	84.57M	68.97M
Interest Expense	12.66M	6.86M	23.25M	26.28M	771K	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	318.71M	358.37M	375.6M	310.37M	273.8M	184.23M	130.41M	86.28M	69.93M
Income Tax Expense	n/a	-152K	-84K	13.41M	5.24M	-2.75M	4.18M	686K	-435K
Shares Outstanding (Basic)	49.51M	43.73M	43.15M	42.44M	37.28M	36.69M	36.61M	29.86M	26.41M
Shares Outstanding (Diluted)	49.51M	43.73M	43.15M	43.91M	37.28M	36.69M	36.65M	29.88M	26.41M
EPS (Basic)	-4.59	-6.02	-6.5	3.01	-2.98	-2.58	2.73	-2.45	-2.38
EPS (Diluted)	-4.59	-6.02	-6.5	2.91	-2.98	-2.58	2.73	-2.45	-2.38
EBITDA	-198.23M	-239.46M	-244.24M	169.54M	-96.83M	-90.34M	92.08M	-73.2M	-64.8M
EBIT	-214.44M	-256.78M	-257.15M	159.98M	-105.24M	-97.49M	88.1M	-75.89M	-65.34M
Depreciation & Amortization	16.21M	17.32M	12.91M	9.56M	8.41M	7.15M	3.98M	2.69M	544K